English  |  正體中文  |  简体中文  |  总笔数 :2854037  
造访人次 :  45382269    在线人数 :  1276
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

跳至:
或输入年份:
从最近的开始 由旧到新排序

显示项目 2235541-2235590 / 2346973 (共46940页)
<< < 44706 44707 44708 44709 44710 44711 44712 44713 44714 44715 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2021-09-04T06:11:48Z Evolution of viral biomarkers in predicting outcomes of chronic hepatitis B patients: From DNA to surface antigen Tseng T.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:48Z Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C Su T.-H.; Liu C.-H.; Liu C.-J.; Chen C.-L.; Ting T.-T.; Tseng T.-C.; Chen P.-J.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏 2021-09-04T06:11:49Z Treatment options for dual HCV/HBV coinfection Liu C.-J.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:49Z Milder clinical manifestation of scrub typhus in Kinmen, Taiwan Su T.-H.; Liu C.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:49Z Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype Huang C.-F.; Yu M.-L.; JIA-HORNG KAO; Tseng T.-C.; Yeh M.-L.; Huang J.-F.; Dai C.-Y.; Lin Z.-Y.; Chen S.-C.; Wang L.-Y.; Juo S.H.H.; Chuang W.-L.; Liu C.-H.
臺大學術典藏 2021-09-04T06:11:50Z Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients Hsu C.-S.; Hsu S.-J.; Chen H.-C.; Liu C.-H.; Jeng J.; Liu C.-J.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:50Z Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection Su T.-H.; Liu C.-J.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Chen C.-L.; Chen P.-J.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏 2021-09-04T06:11:50Z NAFLD in Chinese and South Asian people JIA-HORNG KAO; Amarapurkar D.; Fan J.-G.
臺大學術典藏 2021-09-04T06:11:51Z Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads Tseng T.-C.; Liu C.-J.; Yang H.-C.; Su T.-H.; Wang C.-C.; Chen C.-L.; Hsu C.-A.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:51Z Host Genetic Factors Affecting Spontaneous HBsAg Seroclearance in Chronic Hepatitis B Patients Cheng H.-R.; Liu C.-J.; Tseng T.-C.; Su T.-H.; Yang H.-I.; Chen C.-J.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:51Z Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up Yu M.-L.; Lee C.-M.; Chen C.-L.; Chuang W.-L.; Lu S.-N.; Liu C.-H.; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; JIA-HORNG KAO; Su W.-W.; Lin C.-L.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Liu C.-J.
臺大學術典藏 2021-09-04T06:11:52Z Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients Yuan Q.; Song L.-W.; Liu C.-J.; Li Z.; Liu P.-G.; Huang C.-H.; Yan Y.; Ge S.-X.; Wang Y.-B.; Peng C.-Y.; Zhang J.; JIA-HORNG KAO; Chen D.-S.; Chen P.-J.; Xia N.-S.
臺大學術典藏 2021-09-04T06:11:52Z Hepatitis B virus reactivation in patients receiving cancer chemotherapy: Natural history, pathogenesis, and management Liu C.-J.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:52Z Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion Yang H.-C.; Chen C.-L.; Shen Y.-C.; Peng C.-Y.; Liu C.-J.; Tseng T.-C.; Su T.-H.; Chuang W.-L.; Yu M.-L.; Dai C.-Y.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:53Z Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy Huang Y.-W.; Lin S.-C.; Wei S.-C.; Hu J.-T.; Chang H.-Y.; Huang S.-H.; Chen D.-S.; Chen P.-J.; Hsu P.-N.; Yang S.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:53Z IL-21R gene polymorphisms and serum IL-21 levels predict virological response to interferon-based therapy in Asian chronic hepatitis C patients Hsu C.-S.; Hsu S.-J.; Liu W.-L.; Chen C.-L.; Liu C.-J.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:53Z Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: New trick of old dog Tseng T.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:54Z Risk stratification for hepatitis B virus related hepatocellular carcinoma Lin C.-L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:54Z Fluvastatin helps interferon-based therapy in chronic hepatitis C: Fact or fiction? Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:54Z Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir Wang C.-C.; Tseng K.-C.; Peng C.-Y.; Hsieh T.-Y.; Lin C.-L.; Su T.-H.; Tseng T.-C.; Hsu C.-S.; Lin H.H.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:54Z Revisiting the Stopping Rule for Hepatitis C Genotype 1 Patients Treated with Peginterferon Plus Ribavirin Yu M.-L.; Liu C.-H.; Huang C.-F.; Tseng T.-C.; Huang J.-F.; Dai C.-Y.; Lin Z.-Y.; Chen S.-C.; Wang L.-Y.; Juo S.-H.H.; Chuang W.-L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:55Z Young chronic hepatitis b patients with nucleos(t)ide analogue-induced hepatitis b e antigen seroconversion have a higher risk of HBV reactivation Tseng T.-C.; Liu C.-J.; Su T.-H.; Yang H.-C.; Wang C.-C.; Chen C.-L.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:55Z Clinical and histologic implications of delayed hepatobiliary enhancement on magnetic resonance imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Wei S.-Y.; JIA-HORNG KAO; Lee H.-S.; Shih T.T.-F.
臺大學術典藏 2021-09-04T06:11:55Z Advances in the treatment of chronic hepatitis C: From interferon to direct acting anti-virals Liu C.-J.; Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:56Z Genomic variation-guided management in chronic hepatitis C Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:56Z Persistent hepatitis B viral replication in a FVB/N mouse model: Impact of host and viral factors Chen S.-H.; Wu H.-L.; JIA-HORNG KAO; Hwang L.-H.
臺大學術典藏 2021-09-04T06:11:56Z Non-alcoholic fatty liver disease: An emerging liver disease in Taiwan Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:57Z Association of hepatitis C virus infection and malnutrition-inflammation complex syndrome in maintenance hemodialysis patients Tsai H.-B.; Chen P.-C.; Liu C.-H.; Hung P.-H.; Chen M.-T.; Chiang C.-K.; JIA-HORNG KAO; Hung K.-Y.
臺大學術典藏 2021-09-04T06:11:57Z APASL consensus statements and management algorithms for hepatitis C virus infection Omata M.; Kanda T.; Yu M.-L.; Yokosuka O.; Lim S.-G.; Jafri W.; Tateishi R.; Hamid S.S.; Chuang W.-L.; Chutaputti A.; Wei L.; Sollano J.; Sarin S.K.; JIA-HORNG KAO; McCaughan G.W.
臺大學術典藏 2021-09-04T06:11:58Z Severity of fatty liver on ultrasound correlates with metabolic and cardiovascular risk Wang C.-C.; Tseng T.-C.; Hsieh T.-C.; Hsu C.-S.; Wang P.-C.; Lin H.H.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:58Z Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy Sheng W.-H.; Hung C.-C.; Chang S.-Y.; Liu C.-J.; Chen M.-Y.; Hsieh S.-M.; JIA-HORNG KAO; Chen P.-J.; Chang S.-C.
臺大學術典藏 2021-09-04T06:11:59Z Management of hepatitis C virus infection in the genomic era Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:59Z Hepatitis B virus mutants associated with hepatitis b surface antigen loss: Chicken or egg? Tseng T.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:59Z Erratum: Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update (Hepatology International (2012) 6 (531-561) DOI: 10.1007/s12072-012-9365-4) Liaw Y.-F.; JIA-HORNG KAO; Piratvisuth T.; Chan H.L.Y.; Chien R.-N.; Liu C.-J.; Gane E.; Locarnini S.; Lim S.-G.; Han K.-H.; Amarapurkar D.; Cooksley G.; Jafri W.; Mohamed R.; Hou J.-L.; Chuang W.-L.; Lesmana L.A.; Sollano J.D.; Suh D.-J.; Omata M.
臺大學術典藏 2021-09-04T06:12:00Z Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Hsu S.-J.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:00Z Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load Tseng T.-C.; Liu C.-J.; Yang H.-C.; Su T.-H.; Wang C.-C.; Chen C.-L.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:00Z Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:01Z Host genetic variants and hepatitis b virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission Lin C.-L.; Tseng T.-C.; Su T.-H.; Liu C.-J.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:01Z Serum interleukin 6 level correlates with outcomes of acute exacerbation of chronic hepatitis B Pan C.J.-H.; Wu H.-L.; Kuo S.F.-T.; JIA-HORNG KAO; Tseng T.-C.; Liu C.-H.; Chen P.-J.; Liu C.-J.; Chen D.-S.
臺大學術典藏 2021-09-04T06:12:01Z Impact of hepatitis B virus infection on metabolic profiles and modifying factors Hsu C.-S.; Liu C.-H.; Wang C.-C.; Tseng T.-C.; Liu C.-J.; Chen C.-L.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:02Z Fine mapping of hepatitis B virus pre-S deletion and its association with hepatocellular carcinoma JIA-HORNG KAO; Liu C.-J.; Jow G.-M.; Chen P.-J.; Chen D.-S.; Chen B.-F.
臺大學術典藏 2021-09-04T06:12:02Z Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters Tseng T.-C.; Liu C.-J.; Chen C.-L.; Wang C.-C.; Su T.-H.; Kuo S.F.-T.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:03Z High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load Tseng T.-C.; Liu C.-J.; Yang H.-C.; Su T.-H.; Wang C.-C.; Chen C.-L.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:03Z Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update Liaw Y.-F.; JIA-HORNG KAO; Piratvisuth T.; Chan H.L.Y.; Chien R.-N.; Liu C.-J.; Gane E.; Locarnini S.; Lim S.-G.; Han K.-H.; Amarapurkar D.; Cooksley G.; Jafri W.; Mohamed R.; Hou J.-L.; Chuang W.-L.; Lesmana L.A.; Sollano J.D.; Suh D.-J.; Omata M.
臺大學術典藏 2021-09-04T06:12:04Z Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Wei S.-Y.; JIA-HORNG KAO; Lee H.-S.; Shih T.T.-F.
臺大學術典藏 2021-09-04T06:12:04Z Hepatitis during antituberculosis treatment Wu L.-W.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:04Z Uncovered issues in the overview of nonalcoholic steatohepatitis Wang C.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:04Z Hepatitis C virus and lipid profiles: More questions than answers? Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:05Z Alpha-fetoprotein in chronic hepatitis C Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:05Z Hepatitis B surface antigen quantification: Why and how to use it in 2011 - A core group report Chan H.L.-Y.; Thompson A.; Martinot-Peignoux M.; Piratvisuth T.; Cornberg M.; Brunetto M.R.; Tillmann H.L.; JIA-HORNG KAO; Jia J.-D.; Wedemeyer H.; Locarnini S.; Janssen H.L.A.; Marcellin P.

显示项目 2235541-2235590 / 2346973 (共46940页)
<< < 44706 44707 44708 44709 44710 44711 44712 44713 44714 44715 > >>
每页显示[10|25|50]项目